8 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... and CKD EMPA-REG ... in HF and CKD. ... kidney events in CKD ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #medications #table
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... metformin in T2D and CKD ... cardiovascular disease: CKD ... , #KDIGO2020 #CKD ... in CKD #management
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... Renal #Impairment #CKD ... #Table #GFR #Hypoglycemics
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... pillars of HFrEF GDMT ... diuretics, MRA, SGLT2i ... #CKD #HFrEF #management
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
history of premature CHD ... history of premature CHD ... individuals exhibit CHD ... Family history of CHD ... Family history, CHD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... resynchronization therapy; DM, diabetes ... ejection fraction; GDMT
Dilated Common Bile Duct on POCUS
50's yo patient with RUQ abd pain. Vitals stable/afebrile. Labs: WBC
Common Bile Duct on POCUS ... Vitals stable/afebrile ... mass in distal CBD ... RJonesSonoEM #Dilated #CBD ... #POCUS #ultrasound